Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Vertex Pharmaceuticals Incorporated VRTX

Healthcare  —  Biotechnology
526.19 3.81 0.73% as of 25 Sep
Market cap
$132.3B
P/E
30.4×
S&P 500 Member Revenue Champion (10y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Vertex Pharmaceuticals Incorporated (VRTX) Debt to equity

Vertex Pharmaceuticals Incorporated's debt to equity at the end of the quarter to 30 June 2026 was 0.0×, down 0.0× from fiscal 2025 (0.0×). Over the past ten years it has ranged from 0.0× (fiscal 2025) to 0.7× (fiscal 2015) — the current reading is the lowest in ten years. That is in line with the Biotechnology industry median of 0.0× and in line with the Healthcare sector median of 0.0×.

Debt to equity, annual

Annual

Period Debt to equity Change
FY2025 0.0× —
FY2024 0.0× (67.76%)
FY2023 0.0× (42.78%)
FY2022 0.0× (35.96%)
FY2021 0.1× (14.24%)
FY2020 0.1× (29.58%)
FY2019 0.1× (27.51%)
FY2018 0.1× (55.11%)
FY2017 0.3× (51.58%)
FY2016 0.6× (17.20%)

Quarterly

Period Debt to equity Change
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
Sep 2025 0.0× —
42 more quarters

Against its own ten years

Low 0.0× High 0.7×
Ten-year median 0.1×
Current reading's percentile 9

Debt to equity against peers

Company Debt to equity
VRTX Vertex Pharmaceuticals Incorporated 0.0×
ARGX argenex SE compare 0.0×
REGN Regeneron Pharmaceuticals, Inc. compare 0.1×
MRNA Moderna, Inc. compare 0.1×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 0.2×
RVMD Revolution Medicines, Inc. compare 0.4×
INSM Insmed, Inc. compare 0.7×
ALNY Alnylam Pharmaceuticals, Inc. compare 0.7×
RPRX Royalty Pharma PLC compare 0.9×
Biotechnology industry median 0.0×
Healthcare sector median 0.0×
Market median 0.2×

What Debt to equity is

Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.

(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)

The full definition of Debt to equity →

More on VRTX